Carol Gallagher
New Enterprise Associates Partner
Your Intro Paths to Carol Gallagher
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Carol Gallagher on
cblocation
San Diego, California
investment range
$200k - $40.0m
sweet spot
$10.0m
Carol Gallagher's Past Investments (7)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Pionyr Immunotherapeutics | Series B | $62M (Lead) | Dec 2017 | |
| Metacrine | Series B | $22M (Lead) | Dec 2017 | |
| Good2Go | Seed Round | $7M | Sep 2017 | |
| Good2Go, Inc. | Seed Round | $7M | Sep 2017 | |
| Cleave Biosciences | Series B | $37M (Lead) | Aug 2016 | |
| Millendo Therapeutics | Series B | $62M (Lead) | Jan 2016 | |
| Cleave Biosciences | Series A | $10M | Apr 2013 |
Carol Gallagher's Media
No media found for Carol Gallagher. Add it now.
Your Intro Paths to Carol Gallagher
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Carol Gallagher on
cb